Merck honored on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines
Merck( NYSE MRK), known as MSD outside the United States and Canada, has been named to Fortune’s 2022 Change the World list. The periodic list recognizes companies that have had a positive social impact through conditioning that are part of their core business strategy. Merck was named for its work expanding global access to the company’s mortal papillomavirus( HPV) vaccines.
“ It’s an honor for Merck to be included on Fortune’s 2022 Change the World List, and honored for making our HPV vaccines available to communities around the world, ” said RobertM. Davis, principal administrative officer and chairman, Merck. “ This is the third time over the last five times that our company has been on this list and we’re veritably proud of being conceded for the positive impact we continue to make on global health. Our commitment and sweats in this space reflect Merck’s distinguished heritage of operating responsibly and creating value for society. Importantly, we know that indeed more needs to be done to advance health equity, and our platoon is inspired and passionate about chancing new ways to bring our drugs and vaccines to people and communities far and wide. ”
Merck’s access strategy for our HPV vaccines is completely aligned to the company’s Environmental, Social, Governance( ESG) strategy, and specifically Merck’s commitment to expand access for people and communities around the globe. Among the specific conduct Merck has taken with our HPV vaccines are
uniting with UNICEF on a long- term agreement to give91.5 million boluses for use in Gavi- supported countries from 2021 to 2025;
Making Further than$ 2 billion in capital investments over the last five times to help increase force of our HPV vaccines to extend access encyclopedically;
carrying prequalification in May 2022 from WHO for our HPV vaccines to be used outside the cold chain for over to four days, helping to enhance availability for hard- to- reach populations.
This recognition marks the third time in five times that Merck has been included on Fortune’s Change the World list. Merck was preliminarily honored in 2018 for its leadership in the fight against Ebola, and in 2020 for its impact investing program. Fortune selects companies for this honor grounded on a set of criteria including the measurable social impact of their work to meet unmet social requirements, the links between this work and successful business results, the degree of invention demonstrated and integration of their socially salutary work into their larger commercial identity.
At Merck, known as MSD outside of the United States and Canada, we’re unified around our purpose We use the power of leading- edge wisdom to save and ameliorate lives around the world. For further than 130 times, we’ve brought stopgap to humanity through the development of important drugs and vaccines. We aspire to be the premier exploration- ferocious biopharmaceutical company in the world – and moment, we’re at the van of exploration to deliver innovative health results that advance the forestallment and treatment of conditions in people and creatures. We foster a different and inclusive global pool and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.